GLP-1 Receptor Agonists May Have Little or No Effect on Obesity-Related Cancers

WEDNESDAY, Dec. 10, 2025-- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) seem to have little or no effect on obesity-related cancers, according to a review published online Dec. 8 in the Annals of Internal Medicine.Albert Ko, M.D., from...